Introduction
Tenascin-C (TN-C) is a hexameric extracellular matrix glycoprotein, whose expression is precisely controlled temporally and spatially during embryonic development (Erickson and Bourdon, 1989) . It is expressed at sites where cells undergo extensive epithelial-mesenchymal transformation such as the central and peripheral nervous system, lung, early heart, kidney and teeth (Erickson and Bourdon, 1989) . TN-C is generally found at low levels in the normal adult tissues, but is upregulated in some physiological and pathological conditions including wound healing, in¯ammatory lesions, ®brosis and in cancer tissues (ChiquetEhrismann et al., 1995; Crossin, 1996; Mackie, 1997) . Studies have demonstrated elevated TN-C expression in various human cancers, including breast (Shoji et al., 1992; Yoshida et al., 1997) , lung (Kusagawa et al., 1998) , colon (Sakai et al., 1993; Hanamura et al., 1997) , and liver (Yamada et al., 1992) . TN-C is expressed in both cancer and stromal cells, suggesting a possible role in invasive properties of the cancer cells themselves as well as in the remodeling of cancer stroma. Strong positive TN-C staining is usually associated with stromal ®broblasts surrounding tumor cells, suggesting that TN-C is a stromal marker for epithelial malignancy. Furthermore, positive staining in cancer cells has been associated with unfavorable disease outcome (Yoshida et al., 1995) . The transcriptional factors that regulate TN-C re-expression in tumors are presently unknown.
The transcriptional regulation of the TN-C gene has been investigated in several species including human, mouse, and chicken (Jones et al., 1990; Copertino et al., 1995; Gherzi et al., 1995a) . The nucleotide sequence of the promoter region encompassing about 250 base pairs (bp) upstream of the transcriptional start site is highly conserved among these three species. This promoter region also confers the highest promoter activity in transient transfection assays. In contrast, human and mouse promoter regions upstream of 7250 contain putative negative regulatory elements which may cause repression of TN transcription (Copertino et al., 1995; Gherzi et al., 1995a) . In addition, the ®rst untranslated exon of the human TN gene was shown to contain additional positive and negative regulatory elements (Gherzi et al., 1995b) . Moreover, several regulatory elements including a GCN4/AP-1 like site at position 7146 and an NF-kb element at position 7210 have been characterized by transfection of the 7220 to +79 human promoter construct into primary rat embryo ®broblasts (Mettouchi et al., 1997) . Recent studies of the mouse TN promoter revealed the presence of four distinct protein binding sites, including sites for Krox24 at position 7257, octamer (N-Oct3, N-Oct5A and N-Oct5B) at position 7200, nuclear factor one at position 7180, and an uncharacterized protein that binds to a site called the tenascin control element at position 7247 (Copertino et al., 1997) . Interestingly, dierent combinatorial eects of these elements were found in cells of dierent lineage (Copertino et al., 1997) .
Since TN-C expression is highly regulated during development, transcription factors involved in determining speci®c expression patterns are of particular interest. It has been suggested, based on the tissue culture experiments, that TN-C gene is a target of the homeodomain proteins which can either activate (e.g. Evx-1) or repress (e.g. OTX2) TN-C promoter activity (Jones et al., 1992; Gherzi et al., 1997) . On the other hand, in vivo studies by Meyer et al implicated Fli1 (a member of the Ets family of transcription factors) as a candidate transcription factor regulating TN-C expression during embryogenesis (Meyer et al., 1995) . It was demonstrated by in situ hybridization of Xenopus and avian embryos that expression pattern of Fli1 coincides with sites of cell migration and/or epithelial-mesenchymal transformation (Meyer et al., 1995; Mager et al., 1998) . These sites include migrating cranial neural crest cells, endothelial cells of the heart, and kidney/ pronephric duct, suggesting that Fli1 may regulate a set of genes that are involved in cellular adhesion. Consistent with this notion, putative Fli1 binding sites were found in the promoter regions of a v and b 3 integrins, vitronectin and tenascin. However, the role of Fli1 in regulating expression of these genes has not been directly investigated.
The Ets family of transcription factors shares a highly conserved DNA-binding motif termed the Ets domain, which recognizes purine-rich DNA core motif GGAA/T in the promoter/enhancer regions of many genes. The Ets family consists of over 30 related members which have been found throughout the metazoan world including human, mouse, chicken, sea urchin, Drosophila and C. elegans (Graves and Petersen, 1998; Gysdael and Boureux, 1997; Sharrocks et al., 1997) . The Ets proteins, except for GABPa, bind to their recognition sites as monomers. However, in many cases, the anity of the Ets proteins to their DNA targets is increased by association with other transcription factors including, among others, AP1, Sp1, CBF, C/EBP and SRF (Graves and Peterson, 1998; Ghysdael and Boureux, 1997; Sharrocks et al., 1997; McNagny et al., 1998) . Ets genes have been implicated in cellular proliferation and dierentiation, as well as in tumor formation and metastasis (Graves and Peterson, 1998; Ghysdael and Boureux, 1997; Sharrocks et al., 1997) .
In this study, we have investigated the regulation of the human TN-C promoter and report for the ®rst time that TN-C is regulated by Ets transcription factors in a synergistic interaction with Sp1 and Sp3 in human dermal ®broblasts.
Results

Functional analysis of the TN-C promoter
To identify potential regulatory elements of the human TN-C gene, a series of 5'-deletions of the TN-C promoter linked to the chloramphenicol acetyltransferase reporter gene was generated. These constructs were tested by transient transfection assays in human dermal ®broblasts (Figure 1 ). The 7248 construct showed the highest promoter activity. Subsequent deletions to bp 7133 and 727 decreased promoter activity to 39 and 19%, respectively. The longer constructs with deletion end points at 7516, 71239 and 72100 showed gradual decrease of the promoter activity as compared with the 7248 deletion. These data indicate that TN-C expression is controlled by combination of cis-elements in a similar manner as reported in other cell types (Copertino et al., 1995; Gherzi et al., 1995a) .
Mapping of Fli1 response elements in the TN-C promoter
The expression patterns of TN-C and Fli1 during development has suggested that TN-C gene may be regulated by Fli1 (Meyer et al., 1995; Mager et al., 1998) . To investigate this possibility we focused our studies on the mechanism of TN-C gene regulation by Fli1 in human dermal ®broblasts. To identify the speci®c regions in TN-C promoter that mediate transactivation by Fli1, a series of previously generated 5'-deletion constructs was cotransfected with the Fli1 expression vector. Overexpression of Fli1 strongly activated all the deletion constructs with end-points between 72100 and 7133 with similar potency, whereas 727 deletion was not responsive to Fli1 (Figure 2a ). These results indicate that the TN-C promoter region between bp 7133 and 727 mediates transactivation of this gene by Fli1. The stimulatory eect of Fli1 on TN-C promoter is not the result of nonspeci®c modulation of transcription apparatus due to high level of overexpression, since cotransfection of Fli1 did not have any eect on the activities of vector alone and early SV40 promoter (Figure 2a) . Inspection of the sequence revealed four GGAA/T motifs which are potential binding sites for Ets family proteins. They are henceforth denoted EBSs (Ets Binding Sites) 1 ± 4 (Figure 2b ).
Ets1 and Ets2 are modest activators of the TN-C promoter
The co-transfection experiments presented in Figure 2 indicated that Fli1 is a potent activator of the TN-C promoter in our system. To test whether other Etsfamily members can aect the human TN-C promoter activity, the 7248 TN-C construct was co-transfected with increasing amounts of Ets1, Ets2 or Fli1 expression vectors. As shown in Figure 3 , Fli1 strongly activated the TN-C promoter in a dose dependent manner (over 15-fold), whereas Ets1 and Ets2 had more modest stimulatory eects (3 ± 5-fold).
Fli1 stimulated TN-C mRNA expression levels
To test whether Fli1 is capable of inducing endogenous gene expression, we measured TN-C mRNA levels in ®broblasts transiently transfected with the Fli1 expression vector. Total RNA was prepared from either Fli1 or pSG5 transfected dermal ®broblasts and used for the preparation of cDNA. PCR was performed using dierent cDNA input, with primer pairs speci®c for TN-C, Fli1 and GAPDH. As shown in Figure 4 , signi®cantly higher expression of TN-C mRNA was detected in cells overexpressing Fli1.
Fli1 interacts in vitro with the GGAA motifs in TN-C promoter
We next asked whether any of the four putative EBSs in the TN-C promoter are capable of binding Fli1 in vitro. To test this, we synthesized Fli1 protein in vitro using TNT Coupled Reticulocyte Lysate System (Promega). The size of the in vitro translated . The total amounts of DNA was kept constant by adding pSG5. The graph depicts the TN-C promoter activities relative to the activity of promoter cotransfected wtih pSG5, which was arbitrarily set at 1. Means+ s.e.mean from four independent experiments are presented Fli1 and Sp1 activate TN-C promoter F Shirasaki et al stronger binding was observed with the fragment containing EBS4 (probe D). By contrast, no detectable binding occurred with the fragment containing EBS2 (probe B). The DNA-protein complexes were supershifted with anti-Fli1 antibody indicating that the binding was speci®c. Interestingly, Fli1 binding to DNA was stabilized in the presence of speci®c monoclonal anti-Fli1 antibody. This is likely due to unmasking of the Fli1 DNA-binding domain by the antibody (Watson et al., 1992; Hodge et al., 1996) . To determine whether the GGAA core motifs are responsible for the observed binding, we introduced substitution mutations into these motifs, changing GGA to TTA in the EBS1, 3 and 4 probes. In all cases, mutating the GG motif prevented formation of the DNA-Fli1 complexes (representative data for probe D are shown in Figure 5 right panel).
EBS1, 3 and 4 function as Fli1 response elements
Since Fli1 could bind to EBS1, 3 and 4 in in vitro binding assays, these three sites may mediate transactivation of the TN-C promoter by Fli1. To examine this, the 7133 TN-C promoter constructs carrying the individually mutated GGAA motifs (as described in Figure 5 ) were tested in transient transfection assays (Figure 6 , left panel). Substitution mutations in EBS1, 3 and 4 signi®cantly reduced transactivation by Fli1. Mutation in EBS4 had the greatest eect (2.4-fold reduction) followed by those in EBS1 (twofold) and EBS3 (1.7-fold). Mutating EBS2 did not signi®cantly aect Fli1 transactivation. These data correlate well with the relative anity of those sites to Fli1 ( Figure 5 ) and suggest that EBS1, 3 and 4 are the functional Fli1 response elements in the TN-C promoter. To determine whether these response elements also contribute to the basal promoter activity, the eects of substitution mutations in EBS1 ± 4 were investigated ( Figure 6 , right panel). Mutating either EBS3 or EBS4 resulted in the most signi®cant reduction of the basal promoter activity, while mutating EBS1 has no eect on the basal level. Modest, but consistent reduction of the basal level was observed with the EBS2 mutant. Thus, the four EBSs in the TN-C promoter may have dierent functions: EBS3 and 4 mediate transactivation by Fli1 and contribute to basal promoter activity, EBS1 mediates transactivation by Fli1, but has little eect on the basal activity, and EBS2 contributes modestly to the basal activity but does not function as Fli1 response element.
Nuclear proteins from human dermal fibroblasts interact with the TN-C promoter EMSA were performed to determine which transcription factors may interact with the TN-C promoter in vivo. Speci®cally, we sought to determine the nature of the transcription factors expressed by dermal ®bro-blasts that interact with EBSs. Four probes, A ± D, containing EBS 1 ± 4 respectively, were used for this analysis (as described in Figure 2b ). Representative results of EMSA using a 23 bp TN-C promoter segment containing EBS4 (probe D) and nuclear extracts derived from human dermal ®broblasts are presented in Figure 7 . Three speci®c DNA-protein complexes (denoted 1 ± 3 in Figure 7a , lane 2) were observed. The two complexes below the complex 3 were not competed by an excess of unlabeled wild-type probe (lane 3), suggesting nonspeci®c binding. Complexes 1 ± 3 were all competed by an excess of unlabeled probe D. Furthermore, complexes 1 and 2 were competed by 200-fold excess of a consensus Sp1 oligonucleotide (lane 4) while complex 3 was completed by the addition of the consensus Ets oligonucleotide (lane 5), suggesting that the binding proteins are related to the Sp1 and Ets factors. To test directly whether the GGAA motif is involved in formation of the observed DNA-protein complexes, the 23 bp TN-C promoter segment containing mutated EBS4 motif was used either as a cold competitor (lane 6) or as a probe (lane 7). No competition was observed with the mutated oligo, and no speci®c binding occurred with the mutated probe, suggesting that the GGAA motif is responsible for the formation of these speci®c DNAprotein complexes.
To further characterize the nature of the proteins interacting with this probe, we employed antibodies against two members of the Sp1 family (Sp1 and Sp3) and four members of the Ets family (Ets1, Ets2, Fli1 and GABPa) as well as GABPb1. As shown in Figure  7b , addition of the anti-Sp1 antibody caused a supershift of complex 1 (lane 3), whereas addition of the anti-Sp3 antibody abolished formation of complex 2 (lane 4). When anti-Sp1 and anti-Sp3 antibodies were added simultaneously, formation of complexes 1 and 2 were aected (lane 5). Addition of the anti-Ets1, anti-Ets2, and anti-Fli1 antibodies did not aect formation of the DNA-protein complexes (lanes 6 ± 8). However, addition of the anti-GABPa or b1 antibodies prevented formation of complex 3 (lanes 9 and 10).
Similar EMSA analyses were carried out with probes A, B and C. These studies showed that GABPa interacts with probe C containing EBS3, but does not interact with probes A or B. Furthermore, EMSA with mutated oligonucleotides and antibodies have determined that sequences present at 761 and 7111 are critical for Sp1/Sp3 interaction. The EMSA results are summarized in Figure 7c . Taken together these results indicate that Sp1, Sp3 and GABP interact with several sites within the 7133 to 727 TN-C promoter region. 
Ets factors cooperate with Sp1 to activate the TN-C promoter
It has been well documented that Ets protein cooperate with other transcription factors to regulate expression of target genes (Graves and Petersen., 1998; Ghysdael and Boureux, 1997; Sharrocks et al., 1997; McNagny et al., 1998) . Our analysis of the TN-C promoter raised the possibility that a cooperation between Ets and Sp1 factors may also modulate transcriptional activity of the TN-C promoter. Such experiments are not feasible in human dermal ®broblasts, because of the high endogenous levels of Sp1 in mammalian cells. By contrast, Drosophila SL2 cells have been used extensively for testing the activity of ubiquitous human transcription factors such as Sp1 (Courey and Tjian, 1988) . The results of the synergistic analyses are presented in Figure 8 . The empty pPac Drosophila expression vector did not increase promoter activity. Sp1 (25 ± 250 ng) potently activates the 7133 TN-C promoter in a dose-dependent manner (Figure 8a ). Sp3 activates the TN-C promoter with similar potency (data not shown). Fli1 (50 ± 500 ng) also transactivates the TN-C promoter dose dependently (Figure 8b) . Likewise, GABPa+b1 modestly transactivates the TN-C promoter (Figure 8c ). Simultaneous addition of Sp1 (or Sp3) and Fli1 resulted in synergistic activation of the TN-C promoter activity (Figure 8d) . Similarly, synergistic stimulation was observed when GABPa+b1 were added together with Sp1 or Sp3 (Figure 8e ). Similar data were obtained using the 7248 TN-C promoter (data not shown). We conclude from these experiments that Ets factors and Sp1 cooperate to transactivate the TN-C promoter.
Discussion
The present study of the 5'¯anking region of the human TN-C gene has identi®ed and characterized four GGAA motifs necessary for its function. Full promoter activity depends on the presence of intact Ets and Sp1/Sp3 motifs. These motifs are located within a minimal promoter region between bp 7133 and 727. The signi®cance of these motifs can be further inferred from the previous observations that the proximal 250- bp region of this promoter is highly conserved among human, mouse and chicken (Chiquet-Ehrismann et al., 1995) . Signi®cantly, the most proximal GGAA motif (EBS4) and its¯anking sequences are highly conserved in all three species. EBS1 and 3 are fully conserved in human and mouse promoters, while EBS2 is conserved in human and chicken promoters. Such high level of conservation suggests that these sites play important roles in TN-C gene regulation. This study was conducted in human dermal ®broblasts which are known to have relatively high expression levels of TN-C (Rettig et al., 1994) . We have demonstrated that GABPa, a ubiquitously expressed member of the Ets family, contributes to the activity of the TN-C promoter in dermal ®bro-blasts. Speci®cally, this study shows that GABPa/b1 bind to the EBS3 and 4 and that substitution mutations in each of these two sites signi®cantly decrease the basal promoter activity. Interestingly, overexpression of the GABPa and b1 in ®broblasts did not increase the promoter activity any further, suggesting that endogenous GABP is expressed at the saturation levels (data not shown). Similarly, overexpression of Sp1 or Sp3 in ®broblasts has no stimulatory eects (Ihn and Trojanowska, unpublished observations) . In contrast to GABP, overexpression of other members of Ets family stimulated the TN-C promoter activity. Ets1 and 2 caused a ®vefold increase, while overexpression of Fli1 caused the most dramatic increase, over 15-fold (Figures 2 and 3) . Stimulatory eects of Fli1 were mediated by EBS1, 3 and 4. These three motifs were shown to interact with Fli1 in vitro and substitution mutations in each of these sites signi®cantly reduced transactivation of the TN-C promoter by Fli1 (Figures 5 and 6 ). We have also demonstrated that Sp1 and Sp3 binding sites are located in close proximity to the EBSs in the TN-C promoter. Furthermore, both Sp1 and Sp3 strongly stimulated the activity of the TN-C promoter when tested in Drosophila cells (Figure 8 ). Although Sp3 often functions as a transcriptional repressor (Hagen et al., 1994) , other extracellular matrix genes have been previously shown to be stimulated by this transcription factor (Ihn and Trojanowska, 1997) . The role of Sp1 and Sp3 in regulation of the TN-C promoter has yet to be investigated fully. Cotransfection experiments performed in Drosophila cells, which lack Sp1-like factors, clearly indicate that Sp1 is a potent inducer of TN-C promoter activity, which probably re¯ects its interaction with multiple sites within the TN-C promoter. The formation of multimeric complexes via protein ± protein interaction involving Sp1 molecules and other transcription factors as well as Sp1 and components of the basal transcription apparatus have been shown to facilitate transcription of numerous other genes (Pascal and Tjian, 1991; Verrijzer and Tjian, 1996) . In addition to the Sp1 binding sites identi®ed in this study, additional putative sites are present both downstream from bp 727 and upstream of bp 7133 (Gherzi et al., 1995a) . Future studies are planned to characterize in more detail the role of Sp1 and Sp3 in the TN-C gene regulation.
An important feature of the transcriptional regulation by the Ets proteins is their requirement for cofactors. The Ets factors that bind to DNA as monomers are rather weak activators of transcription and protein ± protein interaction with other factors has been shown to strengthen their transactivating potential, although in some cases it can also lead to transcriptional repression (Sharrocks et al., 1997) . Cooperation between Ets and other factors facilitates binding to sites not matching preferred consensous binding site (Halle et al., 1997) . For example, the GABP complex consists of an Ets family member, GABPa, and an ankyrin repeat-containing protein, GABPb. The GABPa subunits bind weakly to DNA, but binding is signi®cantly increased after association with its partner protein, GABPb. The heterotetramer containing two GABPa/b heterodimers binds to two tandem repeats of the GGA motif (Thompson et al., 1991; Batchelor et al., 1998) . In our study, binding of GABP to the EBS3 and EBS4 which contain two closely positioned tandem repeats of the GGA motifs was demonstrated (Figure 7 ). Other Ets proteins have evolved dierent mechanisms to recruit speci®c partner proteins (Graves and Petersen, 1998; Ghysdael and Boureux, 1997; Sharrocks et al., 1997; McNagny et al., 1998) . Signi®cantly, one such partner protein is Sp1. Some of the examples include synergistic activation of the HTLV1 long terminal repeat by Ets1 and Sp1 (GeÂ gonne et al., 1993) or activation of CD18 promoter by Sp1 and GABP (Rosmarin et al., 1998) . In a recent study of the E-cadherin promoter binding sites for Sp1 and Erg-Fli1 were shown to contribute to the basal promoter activity but possible synergistic interaction between these factors have not been investigated (Gory et al., 1998) . Our study of the TN-C promoter provides evidence for a cooperation between Ets factors and Sp1 in activation of the TN-C promoter activity. The studies performed in Drosophila cells demonstrate that either Fli1 or GABPa+b1 functionally interact with Sp1, resulting in a greater than additive stimulation of the TN-C promoter activity. Taken together, this study shows for the ®rst time that the TN-C gene is regulated by Ets proteins, which together with Sp1 act as potent activators of this gene.
In the context of cultured human dermal ®broblasts, we have shown that Ets proteins transcriptionally activate the TN-C promoter to various degree, with Fli1 having the most potent eects. Signi®cantly, exogenous expression of Fli1 resulted in the increased expression of the endogenous TN-C mRNA (Figure 4 ). Thus, Fli1 is able to interact with the endogenous promoter. Dermal ®bro-blasts unstimulated by cytokines or growth factors express low levels of Ets1 (Gilles et al., 1996) of Fli1 (Shirasaki and Trojanowska, unpublished observations) . This may explain why in the antibody super-shift experiment (Figure 7b ), endogenous Fli1 protein was not detected as a binding factor to EBS4. Another possibility is that the endogenous Fli1 in dermal ®broblasts is in an inactive state under our growth conditions. However, under certain conditions, when elevated levels of active Fli1, Ets1, Ets2 or other family members are present, these factors may contribute to the TN-C gene expression. For example, it has been shown that Ets1 is induced by TNFa, PDGF and bFGF in human dermal ®broblasts (Gilles et al., 1996) . Our preliminary observations suggest that Fli1 is also stimulated by TNFa (Shirasaki and Trojanowska, unpublished data). Interestingly, these cytokines have been shown to induce TN-C expression (Rettig et al., 1994; Makhluf et al., 1996) . TNFa and other growth factors are present in lesional tissues such as rheumatoid arthritis, granulation tissue of healing wounds, and certain tumors, all of which show increased TN-C expression. It is possible that under these conditions Ets factors may play a role in TN-C induction. The nature of the speci®c Ets family member that regulates TN-C expression in vivo may depend on the speci®c tissues or speci®c stimuli.
This study demonstrates that TN-C is a target gene for Ets transcription factors, thus corroborating the previous in vivo observation by Meyer et al. that implicated Fli1 in regulation of TN-C during embryonic development (Meyer et al., 1995; Mager et al., 1998) . A recent work from the same laboratory provides additional support for the role of Fli1 during the process of cell migration (Mager et al., 1998) . Using quail embryo, it was shown that Fli1 is expressed in neural crest cells giving rise to mesenchyme and in mesoderm-derived endothelial cells of forming heart and blood vessels (Mager et al., 1998) . While the expression and function of Fli1 in the adult tissues has been primarily investigated in the hematopoietic cells (Rao et al., 1993; Klemsz et al., 1993; Zhang et al., 1995a) , the observation that Fli1 is expressed in embryonic tissues at the sites of cell migration and epithelial-mesenchymal transformation raises the possibility that it may be reexpressed in certain pathological conditions that are associated with tissue remodeling. Other Ets proteins have been shown to participate in regulation of genes related to tissue remodeling such as metalloproteases (MMPs) (ButticeÁ et al., 1996; Westermarck et al., 1997; Gutman and Wasylyk, 1990; Wasylyk et al., 1991; Buttice and Kurkinen, 1993) and tissue inhibitors of metalloproteases (Edwards et al., 1992; Logan et al., 1996) . TN-C is also expressed at sites of epithelial-mesenchymal transformation (Erickson and Bourdon, 1989) . Interestingly, similar distribution patterns of TN-C and MMPs were observed in the stroma of some tumors, suggesting that TN-C may play a role in tissue restructuring and may in¯uence the expression of genes involved in tissue remodeling and repair (Alexander and Werb, 1991; Tremble et al., 1994) . It is therefore formally possible that Ets proteins may be the conserved developmental regulators of the genes 
Materials and methods
Cell culture
Human foreskin ®broblasts were obtained from foreskins of healthy newborns (following institutional approval and informed consent). Primary explant cultures were established as previously described (Tamaki et al., 1995) . Drosophila Schneider line 2 (SL2) cells were obtained from Dr T Hsu (MUSC) and propagated in Schneider medium (Life Technologies, Inc.) supplemented with 10% heat-treated FCS.
Plasmid constructions
pTN-I-CAT construct was kindly provided by Dr R Gherzi (Gherzi et al., 1995a) . The deletion constructs were generated by PCR using pTN-I-CAT as a template. Substitution mutations were generated using Quick Change site-directed mutagenesis kit (Stratagene) and con®rmed by sequencing. pSG5Fli1, pSG5Ets1, and pSG5Ets2 has been described previously (Watson et al., 1992; Seth et al., 1993) . Plasmids used in transfections of Drosophila cells were generated as follows: Fli1 cDNA was excised by SspI and BamHI from pSG5Fli1. After ®lling-in with Klenow polymerase, the 1386-bp fragment was subcloned at blunt-ended XbaI site of pPacpl (provided by Dr T Hsu, MUSC). The 1951-bp GABPa fragment was excised by XbaI from GABPa/Bluescript (kindly provided by SL McKnight, Tularik Inc, South San Francisco, CA, USA). After ®lling-in, this fragment was subcloned at blunt-ended XbaI site of pPac-pl. The 2663-bp GABPb1 fragment was excised with BamHI and KpnI from the GABPb1/Bluescript (kindly provided by SL McKnight) and subcloned into the BamHI/KpnI site of pPac-pl. The expressed proteins were veri®ed by immunoblot analysis using speci®c antibodies. pPacSp1 and pPacSp3 cloned into pPacSp0 have been described previously (Ihn and Trojanowska, 1997) . Plasmids used in transient transfection assays were puri®ed by double cesium chloride gradients.
Transient transfection and chloramphenicol acetyltransferase assays
Human foreskin ®broblasts were transfected as described previously by the calcium phosphate technique (Tamaki et al., 1995) with 20 mg of various TN-C promoter-chloramphenicol acetyltransferase constructs and various amounts of Ets expression vectors. PSV-b-galactosidase control vector (Promega) was co-transfected to normalize for transfection eciency. Drosophila Schneider cells were transfected as previously described (Ihn and Trojanowska, 1997) . Transfections were performed in duplicates and repeated at least four times using two dierent plasmid preparations. The MannWhitney U-test was used to determine statistical signi®cance.
Reverse transcriptase PCR analysis RT ± PCR was performed using GeneAmp RNA PCR Core kit (Perkin-Elmer) according to the manufacturer's protocol. Brie¯y, total RNA was harvested (Chomczynski and Sacchi, 1987) from either Fli1 or pSG5 transfected dermal ®bro-blasts. One mg of total RNA was reverse-transcribed using oligo d(T) 16 . Dierent amounts of the reverse-transcribed products (1/10, 1/20 and 1/50 of the total cDNA products) were ampli®ed. The following primer pairs were used for ampli®cation: TN-C forward primer, CAGCTCCACACTC-CAGGTAC; TN-C reverse primer, CTTTCGCTGG-GCTCTGAAGG: Fli1 forward primer, CCTGGAGGGG-CACAAACGAT; Fli1 reverse primer, GCTTCTAGTAG-TAGCTGCCTAAGTG; GAPDH forward primer, TGA-AGGTCGGAGTCAACGGATTTGGT; GAPDH reverse primer, CATGTGGGCCATGAGGTCCACCAC. The primers were mRNA speci®c in that the recognition sites of the upstream and downstream primers resided in separate exons in genomic sequence. The sizes of PCR products for TN-C, Fli1, and GAPDH were 448, 638 and 980 bp, respectively. The PCR products were separated by agarose gel electrophoresis and stained with ethidium bromide.
Preparation of nuclear extracts
Nuclear extracts were prepared according to Andrews and Faller (1991) with minor modi®cations as previously described (Tamaki et al., 1995) . In vitro transcribed and translated human Fli1 protein was prepared using TNT Coupled Reticulocyte Lysate System (Promega). Protein production was con®rmed by immunoblotting assay using anti-Fli1 antibody (Zhang et al., 1995b) .
Electrophoretic mobility shift assay (EMSA)
Oligonucleotides used as probes and competitors were purchased from Medical University of South Carolina Core Facility. Radioactive double-stranded probes for electrophoretic mobility shift assays were 5'-end labeled using T4 polynucleotide kinase and [g-32 P]ATP. DNA mobility shift assay was performed as described previously (Tamaki et al., 1995) . Brie¯y, 5 mg of nuclear extracts or 2 ml of in vitro translated proteins were incubated for 30 min on ice in 24 ml binding buer (10 mM HEPES-KOH, pH 7.9, 50 mM NaCl, 1 mM MgCl 2 , 0.5 mM EDTA, 1 mM dithiothreitol, 0.7 mM phenylmethyl-sulfonyl¯uoride, 10% glycerol, 10 mg/ml aprotinin, 2 mg/ml leupeptin, and 2 mg/ml pepstatin) containing 50 000 c.p.m. labeled probe and 0.2 ± 1 mg of poly(dI-dC)-poly(di-dC). In some assays, double-stranded competitors (200-fold molar excess) or antibodies were preincubated with nuclear extracts 30 min prior to addition of radioactive oligonucleotide probe. Polyclonal anti-Sp1 and anti-Sp3 antibodies were purchased from Santa Cruz Biotechnology. Monoclonal anti-Ets1, anti-Ets2 and anti-Fli1 antibodies were previously characterized (Zhang et al., 1995b; Koizumi et al., 1990; Fujiwara et al., 1990; Hodge et al., 1996) . Polyclonal anti-GABPa and anti-GABPb1 were kindly provided by Dr SL McKnight (Tularik Inc). Separation of free radiolabeled DNA from DNA-protein complexes was carried out on a 5% nondenaturing polyacrylamide gel. Electrophoresis was performed in 0.256Tris-borate electrophoresis buer at 250 V at 48C. The gels were dried and exposed to X-ray ®lm at 7808C.
